Aptevo Therapeutics
Aptevo Therapeutics develops multispecific immunotherapies for cancer using its ADAPTIR and ADAPTIR-FLEX platform technologies.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 17Latest story
November 2026
October 2026
September 2026
August 2026
June 2026